Delivery Order SPE2DB22D2103-SPE2DB25FR8LY
Award Date
11/4/24
Potential Completion Date
11/5/24
Potential Value
$38K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3304|SPE2DB25FW6B8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,418.24 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $8,030.70 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The...
This federal contract award, with ID SPE2DB22D1200|SPE2DB25FN0AH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $45,831.25 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
This federal contract award, with the ID SPE2DB20D1051|SPE2DB25FD7AF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,173.26 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of February 18, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,071.27 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, with an ultimate completion date of June 24, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with the identifier SPE2DB20D1047|SPE2DB25FF46G, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,059.76 firm fixed-price delivery order is for the procurement of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $10,833.79 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has a performance period through March 12, 2025 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFKQU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,483.19 firm fixed price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,549.80 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award SPE2DB20D1100|SPE2DB25FA6B6 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $15,579.22 firm fixed price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...